Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rubin

Showing results (1081-1090 of 1,202) with videos related to

Pageof 121
Sort By:
Infection Prevention in Practice|May 27, 2026
Implementing a participant-driven water management initiative to support Maryland hospitalsN Exum, S Ryan, D L Mensah, et al.
Journal of the American College of Cardiology|December 21, 2013
Updated treatment algorithm of pulmonary arterial hypertensionNazzareno Galiè, Paul A Corris, Adaani Frost, et al.
American Journal of Respiratory and Critical Care Medicine|March 24, 2007
Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertensionAnastasia Anthi, Roberto F Machado, Maria L Jison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancyH C Pitot, R M Goldberg, J M Reid, et al.
Journal of the American College of Cardiology|November 14, 2009
Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertensionRonald J Oudiz, Nazzareno Galiè, Horst Olschewski, et al.
American Heart Journal|January 21, 2014
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized studyKelly M Chin, David B Badesch, Ivan M Robbins, et al.
The European Respiratory Journal|August 19, 2017
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertensionSean Gaine, Kelly Chin, Gerry Coghlan, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Novel Pyrazole-Containing Compounds Active against <i>Mycobacterium tuberculosis</i>Giovanna Poce, Sara Consalvi, Giulia Venditti, et al.
Circulation|April 16, 2019
Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial HypertensionKelly M Chin, Lewis J Rubin, Richard Channick, et al.
Frontiers in Plant Science|May 31, 2023
Sainfoin (<i>Onobrychis</i> spp.) crop ontology: supporting germplasm characterization and international research collaborationsEbrar Karabulut, Kübra Erkoç, Murat Acı, et al.
Pageof 121

Showing results (1081-1090 of 1,202) with videos related to

Sort By:
Pageof 121
Infection Prevention in Practice|May 27, 2026
Implementing a participant-driven water management initiative to support Maryland hospitalsN Exum, S Ryan, D L Mensah, et al.
Journal of the American College of Cardiology|December 21, 2013
Updated treatment algorithm of pulmonary arterial hypertensionNazzareno Galiè, Paul A Corris, Adaani Frost, et al.
American Journal of Respiratory and Critical Care Medicine|March 24, 2007
Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertensionAnastasia Anthi, Roberto F Machado, Maria L Jison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 29, 2000
Phase I dose-finding and pharmacokinetic trial of irinotecan hydrochloride (CPT-11) using a once-every-three-week dosing schedule for patients with advanced solid tumor malignancyH C Pitot, R M Goldberg, J M Reid, et al.
Journal of the American College of Cardiology|November 14, 2009
Long-term ambrisentan therapy for the treatment of pulmonary arterial hypertensionRonald J Oudiz, Nazzareno Galiè, Horst Olschewski, et al.
American Heart Journal|January 21, 2014
Two formulations of epoprostenol sodium in the treatment of pulmonary arterial hypertension: EPITOME-1 (epoprostenol for injection in pulmonary arterial hypertension), a phase IV, open-label, randomized studyKelly M Chin, David B Badesch, Ivan M Robbins, et al.
The European Respiratory Journal|August 19, 2017
Selexipag for the treatment of connective tissue disease-associated pulmonary arterial hypertensionSean Gaine, Kelly Chin, Gerry Coghlan, et al.
ACS Medicinal Chemistry Letters|October 18, 2019
Novel Pyrazole-Containing Compounds Active against <i>Mycobacterium tuberculosis</i>Giovanna Poce, Sara Consalvi, Giulia Venditti, et al.
Circulation|April 16, 2019
Association of N-Terminal Pro Brain Natriuretic Peptide and Long-Term Outcome in Patients With Pulmonary Arterial HypertensionKelly M Chin, Lewis J Rubin, Richard Channick, et al.
Frontiers in Plant Science|May 31, 2023
Sainfoin (<i>Onobrychis</i> spp.) crop ontology: supporting germplasm characterization and international research collaborationsEbrar Karabulut, Kübra Erkoç, Murat Acı, et al.
Pageof 121